EurekAlert! Cancer Research - Multimedia

Home

MENU

Topic Home
News Releases
Multimedia

Topic Home
News Releases
Multimedia

Multimedia

Updates every hour. Last Updated: 23-Oct-2026 04:16 ET (23-Oct-2026 08:16 GMT/UTC)

Patient cohort. — Patient cohort.First Hospital of Jilin University

CNAs in patients with bile positive TF. — CNAs in patients with bile positive TF.First Hospital of Jilin University

Visual abstract — Visual abstractFirst Hospital of Jilin University

Overview of post-translational modifications (PTMs) regulating RAS proteins. — Overview of post-translational modifications (PTMs) regulating RAS proteins....ELSP

Graphical abstract of the workflow of the study and significant findings. — Graphical abstract of the workflow of the study and significant findings....Compuscript Ltd

Functional plasticity of three differentiated NPC states: edNPCs reshaping TIME, tdNPCs reprogramming cellular metabolism, and ldNPCs overactivating the cell cycle. — Functional plasticity of three differentiated NPC states: edNPCs reshaping TIME, tdNPCs reprogramming cellular metabolis...Compuscript Ltd

Cellular communication analysis identifies DLL3 as a pivotal hub bridging malignant progression and immunosuppression. — Cellular communication analysis identifies DLL3 as a pivotal hub bridging malignant progression and immunosuppression....Compuscript Ltd

Common Sense Oncology — Common Sense OncologyEuropean Organisation for Research and Treatment of Cancer

European Organisation for Research and Treatment of Cancer — European Organisation for Research and Treatment of Cancer...European Organisation for Research and Treatment of Cancer

circLPAR3 is verified and characterized in docetaxel-resistant prostate cancer cells. — circLPAR3 is verified and characterized in docetaxel-resistant prostate cancer cells....Compuscript Ltd

PCBP2 is a mediating RBP for circLPAR3 and CHAC1. — PCBP2 is a mediating RBP for circLPAR3 and CHAC1.Compuscript Ltd

circLPAR3 increased prostate cancer cell proliferation and docetaxel resistance in CDX models. — circLPAR3 increased prostate cancer cell proliferation and docetaxel resistance in CDX models....Compuscript Ltd

17
18
19
20
21

Copyright © 2026 by the American Association for the Advancement of Science (AAAS)

facebook.com/EurekAlert
@EurekAlert
youtube.com/EurekAlert

Help / FAQ
Services
Eligibility Guidelines
Contact EurekAlert!

Terms & Conditions
DMCA
Privacy Policy
Disclaimer

Copyright © 2026 by the American Association for the Advancement of Science (AAAS)